Please login to the form below

Not currently logged in
Email:
Password:

Truberzi

This page shows the latest Truberzi news and features for those working in and with pharma, biotech and healthcare.

NICE backs Allergan's IBS therapy Truberzi

NICE backs Allergan's IBS therapy Truberzi

NICE backs Allergan's IBS therapy Truberzi. The £3 per day therapy was recommended in final guidance from the cost-effectiveness watchdog. ... For doctors to now be able to prescribe Truberzi, a targeted treatment, this will signify real change for

Latest news

  • HIV prevention pill heads July CHMP recommendations HIV prevention pill heads July CHMP recommendations

    Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics